The clinical research unit (CRU) addresses the pathophysiological pathways governing organ dysfunction triggered by systemic inflammation in an integrated approach within translational projects. The project Z will enforce the translation from basic science to the clinical application. All projects rely on the exchange of scientific expertise, research methods, resources and patient material which all will be brought together in this project. The project Z will provide a common interface within the CRU that will address this need for cooperativity and interactions among the projects.
We will provide research infrastructure to test novel findings regarding their general pathophysiological relevance and clinical translational value. We will develop and offer sophisticated technologies for functional ex vivo analysis of patient-derived samples. By immunephenotyping we will provide a very versatile and unmatched tool for the systematic broad-spectrum analysis of the phenotypic and functional appearance of a wide array of leukocyte subsets in the context of systemic inflammatory disorders. This will be complemented by analysis of soluble markers using multiplex-based system to enable the simultaneous measurement of up to 50 different parameters from a single sample. Using functional assays and imaging flow cytometry, we will transfer and confirm data obtained in individual projects in clinical cohorts down to specific signaling pathways.
All projects in this CRU will produce large raw datasets derived from a wide range of technologies. Analyzing such complex datasets requires profound bioinformatic knowledge. We will bundle the essential statistic expertise, addressing the challenges of comparison of multiform scientific datasets, improve available and develop novel data analysis strategies. Bringing together the initially project-specific and separated datasets will open up the way towards novel integrated analysis algorithms. Such integrated analyses of basic science and clinical data are only possible within a research network. We hope to transfer basic science results into the clinical context to enable the development of innovative new therapeutic approaches for patients with systemic inflammatory disorders.